MedTrace Logo

ARTISS a Single-centre Randomised Control Study

NCT04931615 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2024-03-13

No results posted yet for this study

Summary

The Influence of ARTISS on post-operative abdominal drainage and seroma formation in DIEP/MS-TRAM free flap breast reconstruction patients.

Conditions

  • Breast Neoplasms
  • Mammaplasty

Interventions

DRUG

ARTISS 4mL Fibrin Sealant Topical Solution (Frozen)

Wound sealant

OTHER

no ARTISS

Wound closed without sealant

Sponsors & Collaborators

  • Mid and South Essex NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Mary Morgan, MD · Mid and South Essex NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-01
Primary Completion
2023-02-28
Completion
2023-02-28

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04931615 on ClinicalTrials.gov